Analysis of the Concerted Metalation-Deprotonation Mechanism in Palladium-Catalyzed Direct Arylation Across a Broad Range of Aromatic Substrates
摘要:
The concerted metalation-deprotonation mechanism predicts relative reactivity and regioselectivity for a diverse set of arenes spanning the entire spectrum of known palladium-catalyzed direct arylation coupling partners. An analysis following an active strain model provides a more complete portrayal of the important arene/catalyst parameters leading to a successful coupling. The breadth of arenes whose reactivity can be predicted by the CMD mechanism indicates that it may be far more widespread than previously imagined.
Analysis of the Concerted Metalation-Deprotonation Mechanism in Palladium-Catalyzed Direct Arylation Across a Broad Range of Aromatic Substrates
作者:Serge I. Gorelsky、David Lapointe、Keith Fagnou
DOI:10.1021/ja802533u
日期:2008.8.1
The concerted metalation-deprotonation mechanism predicts relative reactivity and regioselectivity for a diverse set of arenes spanning the entire spectrum of known palladium-catalyzed direct arylation coupling partners. An analysis following an active strain model provides a more complete portrayal of the important arene/catalyst parameters leading to a successful coupling. The breadth of arenes whose reactivity can be predicted by the CMD mechanism indicates that it may be far more widespread than previously imagined.
THERAPEUTIC USE OF ACTIVATORS OF ZINC FINGER PROTEIN GLI3
申请人:Universität Leipzig
公开号:EP2806884A1
公开(公告)日:2014-12-03
Therapeutic Use of Activators of Zinc Finger Protein GL13
申请人:Universtität Leipzig
公开号:US20140336111A1
公开(公告)日:2014-11-13
The present invention relates to the therapeutic use of activators of the zinc finger protein GLI3 in diseases that are associated with reduced Hedgehog signaling in hepatocytes, in particular Polycystic ovary syndrome, Steatosis hepatis, Steatohepatit is and/or Adipositas. The invention further relates to methods of treating an individual with said activator, a pharmaceutical composition comprising said activator and the use of said activator as food supplement.
US9540648B2
申请人:——
公开号:US9540648B2
公开(公告)日:2017-01-10
[EN] THERAPEUTIC USE OF ACTIVATORS OF ZINC FINGER PROTEIN GLI3<br/>[FR] UTILISATION THÉRAPEUTIQUE D'ACTIVATEURS DE LA PROTÉINE À DOIGT DE ZINC GLI3
申请人:UNIV LEIPZIG
公开号:WO2013110749A1
公开(公告)日:2013-08-01
The present invention relates to the therapeutic use of activators of the zinc finger protein GLI3 in diseases that are associated with reduced Hedgehog signaling in hepatocytes, in particular Polycystic ovary syndrome,Steatosis hepatis, Steatohepatitis and/or Adipositas. The invention further relates to methods of treating an individual with said activator, a pharmaceutical composition comprising said activator and the use of said activator as food supplement.